Table 2.
Region, positiona | Index SNP, (n), nearest gene | Alleles (E/R), EAF | Cancer Type | OR (95% CI) | P | ASSET model, Phetb | r2c |
---|---|---|---|---|---|---|---|
A: From the three-cancer meta-analysis | |||||||
Associations with breast, ovarian and prostate cancer risk with the same direction of effect | |||||||
2q13 | rs17041869 | A/G | Breast cancer | 0.97 (0.94–0.99) | 7.1×10−3 | 3-cancer | 1d |
111896243 | (3) | 0.88 | Ovarian cancer | 0.93 (0.88–0.97) | 5.3×10−4 | 0.07 | 1d |
BCL2L11 | Prostate cancer | 0.92 (0.89–0.95) | 2.6×10−6 | 1d | |||
Meta-analysis | 0.94 (0.93–0.96) | 5.1×10−9 | |||||
11q12 | rs7937840 | T/C | Breast cancer | 1.04 (1.02–1.06) | 3.6×10−5 | 3-cancer | 0.89 |
61893972 | (1) | 0.26 | Ovarian cancer | 1.05 (1.01–1.09) | 5.8×10−3 | 0.95 | 0.90 |
INCENP | Prostate cancer | 1.05 (1.02–1.08) | 8.9×10−4 | 0.89 | |||
Meta-analysis | 1.05 (1.03–1.06) | 5.0×10−9 | |||||
19p13 | rs1469713 | A/G | Breast cancer | 0.95 (0.94–0.97) | 9.9×10−8 | 3-cancer | 0.98 |
19528806 | (89) | 0.64 | Ovarian cancer | 0.96 (0.93–0.99) | 6.3×10−3 | 0.64 | 0.98 |
GATAD2A | Prostate cancer | 0.97 (0.94–0.99) | 1.0×10−2 | 0.95 | |||
Meta-analysis | 0.96 (0.95–0.97) | 3.4×10−10 | |||||
B: From the pairwise meta-analyses | |||||||
Associations with breast and ovarian cancer risk with the same direction of effect | |||||||
9q31 | rs200182588 | G/GGC | Breast cancer | 0.96 (0.94–0.98) | 1.9×10−5 | 2-cancer | 0.81 |
106856690 | (15) | 0.56 | Ovarian cancer | 0.93 (0.89–0.96) | 2.8×10−6 | 0.08 | 0.82 |
SMC2 | Meta-analysis | 0.95 (0.94–0.97) | 8.9×10−9 | ||||
15q26 | rs8037137 | T/C | Breast cancer | 1.07 (1.04–1.10) | 1.8×10−7 | 2-cancer | 0.98 |
91506637 | (33) | 0.86 | Ovarian cancer | 1.09 (1.04–1.14) | 2.1×10−4 | 0.58 | 0.98 |
RCCD1 | Meta-analysis | 1.07 (1.05–1.10) | 9.1×10−10 | ||||
Associations with breast and prostate cancer risk with the same direction of effect | |||||||
1p34 | rs5013329 | T/C | Breast cancer | 1.04 (1.02–1.06) | 7.8×10−6 | 2-cancer | 0.98 |
46815091 | (218) | 0.31 | Prostate cancer | 1.07 (1.04–1.10) | 1.4×10−7 | 0.09 | 0.98 |
NSUN4 | Meta-analysis | 1.05 (1.04–1.07) | 1.8×10−11 | ||||
6q23 | rs9375701 | T/C | Breast cancer | 1.04 (1.02–1.06) | 3.6×10−6 | 2-cancer | 0.99 |
130384057 | (53) | 0.67 | Prostate cancer | 1.06 (1.03–1.08) | 1.5×10−5 | 0.41 | 0.99 |
L3MBTL3 | Meta-analysis | 1.05 (1.03–1.06) | 3.4×10−10 |
Abbreviations: n, Number of SNPs with P < 10−8 within 1 Mb of the index SNP; (E/R), (effect/reference) alleles; EAF: effect allele frequency.
Build 37 coordinates.
Cochran’s Q-test for heterogeneity P-value.
Imputation accuracy, r2, in iCOGS European samples.
Genotyped SNP.